BIAF: Positive Preclinical Findings
BIAF bioAffinity Technologies reports positive preclinical findings showing proprietary gene silencing technology is selectively cytotoxic to squamous skin cancer cells without harming healthy cells
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.